Exscientia has a total of 138 patents globally, out of which 20 patents have been granted. Of these 138 patents, more than 79% of patents are active. The United Kingdom is where Exscientia has filed the maximum number of patents, followed by United States of America and Europe (EPO). Parallelly, the UK seems to be the main focused R&D center and is also the origin country of Exscientia.
Exscientia was founded in the year 2012 by Andrew Hopkins. The company is a pharmatech business that designs and discovers new medications using an end-to-end AI platform.
Do read about some of the most popular patents of Exscientia which have been covered by us in this article and also you can find Exscientia’s patents information, the worldwide patent filing activity, its patent filing trend over the years, and many other stats over Exscientia’s patent portfolio.
How many patents does Exscientia have?
Exscientia has a total of 138 patents globally. These patents belong to 30 unique patent families. Out of 138 patents, 109 patents are active.
How Many Patents did Exscientia File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Exscientia Applications Filed | Exscientia Patents Granted |
| 2024 | 8 | 7 |
| 2023 | 34 | 4 |
| 2022 | 20 | 7 |
| 2021 | 32 | 1 |
| 2020 | 10 | – |
| 2019 | 9 | 1 |
| 2018 | 10 | – |
| 2017 | 2 | – |
| 2015 | 8 | – |
| 2010 | 5 | – |
How many Exscientia patents are Alive/Dead?
How Many Patents did Exscientia File in Different Countries?
Countries in which Exscientia Filed Patents
| Country | Patents |
| United Kingdom | 22 |
| Europe (EPO) | 14 |
| United States of America | 14 |
| Australia | 8 |
| Japan | 7 |
| Mexico | 7 |
| Brazil | 6 |
| Singapore | 6 |
| India | 5 |
| Israel | 5 |
| New Zealand | 5 |
| Colombia | 4 |
| South Africa | 4 |
| Canada | 4 |
| Germany | 3 |
| Chile | 2 |
| China | 2 |
| Austria | 1 |
| Peru | 1 |
| Poland | 1 |
| Spain | 1 |
| Hong Kong (S.A.R.) | 1 |
Where are Research Centres of Exscientia Patents Located?
Centaur AI, as well as AI pharma tech, are among the AI-focused drug design and discovery systems developed by Exscientia. The time-consuming process of drug discovery and design is substantially sped up with these technologies.
Their platform demonstrated for the first time in a prospective interventional trial that functional precision-oncology can improve patient outcomes in the landmark EXALT1 clinical study.
EXALT1 is the world’s first prospective interventional study. Based on testing drug reactions ex vivo in patients’ own tissue samples, the platform’s predictions suggested which therapy would be most beneficial for late-stage hematological cancer patients.
Exscientia has delivered its first two AI-designed medicinal compounds to clinical trials, the first for Alzheimer’s disease symptoms and the second for cancer immunotherapy, in collaboration with Sumitomo Dainippon Pharmaceutical.
10 Best Exscientia Patents
WO2022167821A1 is the most popular patent in the Exscientia portfolio. It has received 5 citations so far from company like Genentech.
| Publication Number | Citation Count |
| WO2022167821A1 | 5 |
| WO2022134641A1 | 4 |
| WO2023180189A1 | 3 |
| WO2022134642A1 | 3 |
| WO2022106857A1 | 2 |
| US20200064348A1 | 2 |
| CN111295588A | 2 |
| WO2024057013A1 | 1 |
| US11486876B2 | 1 |
| WO2022084696A1 | 1 |
What are Exscientia key innovation segments?
What Technologies are Covered by Exscientia?
The chart below distributes patents filed by Exscientia in different countries on the basis of the technology protected in patents. It also represents the markets where Exscientia thinks it’s important to protect particular technology inventions.
R&D Focus: How has Exscientia search focus changed over the years?
EXCLUSIVE INSIGHTS COMING SOON!
Interested in knowing about the areas of innovation that are being protected by Exscientia?